"Depuis 2008, l'Hôpital privé Jean Mermoz, établissement du groupe Ramsay Santé, à Lyon développe une politique de soins dont les valeurs de proximité, de compétences et d'écoute sont appliquées au quotidien. Avec les 150 praticiens que compte cet établissement (l'un des plus importants de la région Rhône-Alpes), vous aurez l'assurance de bénéficier d'une offre de soins diversifiée et dispensée au sein d'une structure médicale dotée d'un plateau technique de haut niveau."

During the past decade, Hopital privé Jean Mermoz conducted 81 clinical trials. In the 10-year time frame, 81 clinical trials started and 8 clinical trials were completed, i.e. on average, 9.9% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 8 clinical trials were completed. i.e. 19.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital privé Jean Mermoz" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 19 trials, followed by "UNICANCER" with 10 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 9 trials sponsored, "Centre Leon Berard" with 8 trials sponsored and "ARCAGY/ GINECO GROUP" with 8 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital privé Jean Mermoz" #1 collaborator was "European Clinical Trial Experts Network" with 6 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "Roche Pharma AG" with 3 trials as a collaborator and "UNICANCER" with 3 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Hopital privé Jean Mermoz" are "Breast Cancer" (7 trials), "Colorectal Cancer" (4 trials), "Colorectal Cancer Metastatic" (4 trials), "Colorectal Adenocarcinoma" (3 trials) and "Latarjet" (3 trials). Many other conditions were trialed in "Hopital privé Jean Mermoz" in a lesser frequency.

Most popular intervention types in "Hopital privé Jean Mermoz" are "Drug" (69 trials), "Other" (21 trials), "Procedure" (16 trials), "Biological" (7 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (13 trials), "Paclitaxel" (5 trials), "Placebo" (5 trials), "Irinotecan" (4 trials) and "Niraparib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hopital privé Jean Mermoz" are 92 trials for "All" genders, 14 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital privé Jean Mermoz". 4 are not yet recruiting, 33 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Hopital privé Jean Mermoz, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital privé Jean Mermoz, 1 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 21 trials that are defined as “Not Applicable".

Hopital privé Jean Mermoz has several departments that took part in Clinical trials: "Hopital Prive Jean Mermoz; Cancerologie" - 4 trials, "HOP Prive Arras Les Bonnettes; Chimiotherapie" - 4 trials, "GCS Centre de Cardiologie du Pays Basque" - 2 trials, "Service Cancerologie Polyclinique Clairval" - 2 trials, "Hopital Prive Villeneuve d Ascq;Chimiotherapie Radiotherapie" - 2 trials, "Service d'Urologie Générale de Santé - Hôpital Privé La Louvière" - 2 trials